Mark L. Pacala - 18 Nov 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Mark L. Pacala
Issuer symbol
TOI
Transactions as of
18 Nov 2025
Net transactions value
-$200,000
Form type
4
Filing time
20 Nov 2025, 16:55:03 UTC
Previous filing
28 Mar 2025
Next filing
24 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pacala Mark L Director C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD, SUITE 800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-Fact for Mark L. Pacala 20 Nov 2025 0001321250

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Sale $8,640 -2,160 -0.96% $4.00 222,811 18 Nov 2025 Direct F1
transaction TOI Common Stock Sale $4,840 -1,210 -0.54% $4.00 221,601 18 Nov 2025 Direct F1
transaction TOI Common Stock Sale $186,520 -46,630 -21% $4.00 174,971 18 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents sale of Common Stock acquired from previously vested RSU awards.